Cinnamaldehyde changes the dynamic balance of glucose metabolism by targeting ENO1

Life Sci. 2020 Oct 1:258:118151. doi: 10.1016/j.lfs.2020.118151. Epub 2020 Jul 26.

Abstract

Aims: Hepatic glucose metabolism involves a variety of catabolic and anabolic pathways, and the dynamic balance of glucose metabolism is regulated in response to environmental and nutritional changes. The molecular mechanism of glucose metabolism in liver is complex and has not been fully elucidated so far. In this study, we hope to elucidate the target and mechanism of cinnamaldehyde (CA) in regulating glucose metabolism.

Materials and methods: Molecular image tracing and magnetic capture in combination with an alkynyl-CA probe (Al-CA) was used to show CA covalently binds to α-enolase (ENO1) in both mouse liver and HepG2 cells. Accurate metabolic flow assays subsequently demonstrated that the utilization of glycogenic amino acids and the biosynthesis of tricarboxylic acid (TCA) cycle intermediates were strengthened, which was detected using nontargeted and targeted metabolomics analyses.

Key findings: Our study shows that CA covalently bonds with ENO1, which affects the stability and activity of ENO1 and changes the dynamic balance of glucose metabolism. The interruption of gluconeogenic reflux by ENO1 enhanced TCA cycle, and eventually led to a decrease in blood glucose and the improvement of mitochondrial efficiency.

Significance: These results provide a detailed description of how CA maintains the dynamic balance of glucose utilization and improves energy metabolism.

Keywords: Cinnamaldehyde (CA); Gluconeogenesis; Glycogen synthesis; Glycolysis; α-Enolase (ENO1).

MeSH terms

  • Acrolein / analogs & derivatives*
  • Acrolein / pharmacology
  • Animals
  • Biomarkers, Tumor / metabolism*
  • Citric Acid Cycle / drug effects
  • DNA-Binding Proteins / metabolism*
  • Energy Metabolism / drug effects
  • Enzyme Activation / drug effects*
  • Flavoring Agents / pharmacology*
  • Gluconeogenesis / drug effects*
  • Glucose / metabolism*
  • Glycolysis / drug effects
  • Hep G2 Cells
  • Humans
  • Mice
  • Molecular Docking Simulation
  • Phosphopyruvate Hydratase / metabolism*
  • Tumor Suppressor Proteins / metabolism*

Substances

  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • Flavoring Agents
  • Tumor Suppressor Proteins
  • Acrolein
  • ENO1 protein, human
  • Eno1 protein, mouse
  • Phosphopyruvate Hydratase
  • Glucose
  • cinnamaldehyde